Crosspoint Capital Strategies’s Thermo Fisher Scientific TMO Stock Holding History

Crosspoint Capital Strategies’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-70	Closed	-$9K	–	745
2015 Q4	$9K	Sell	70 -2,402	-97%	-$320K	﹤0.01%	714
2015 Q3	$302K	Sell	2,472 -354	-13%	-$46.1K	0.35%	72
2015 Q2	$367K	Hold	2,826	–	–	0.1%	116
2015 Q1	$380K	Sell	2,826 -8,585	-75%	-$1.11M	0.18%	96
2014 Q4	$1.43M	Buy	11,411 +2,836	+33%	+$345K	0.5%	57
2014 Q3	$1.04M	Buy	8,575 +112	+1%	+$13.6K	0.77%	35
2014 Q2	$1.05M	Buy	8,463 +1,056	+14%	+$124K	0.4%	64
2014 Q1	$891K	Buy	7,407 +90	+1%	+$10.7K	0.36%	56
2013 Q4	$917K	Buy	+7,317	New	+$728K	0.31%	63

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Crosspoint Capital Strategies's TMO Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Thermo Fisher Scientific (TMO) in Q1 2016, closing a stake of 70 shares — an estimated $9K sold.

Crosspoint Capital Strategies first reported a position in TMO in Q4 2013 and held it in 9 quarters. The position peaked at $1.43M in Q4 2014. 1,024 funds tracked by Wall St. Rank hold TMO as of Q1 2016.

Crosspoint Capital Strategies reported no remaining Thermo Fisher Scientific position as of Q1 2016 after selling out during the quarter.
Crosspoint Capital Strategies sold 70 Thermo Fisher Scientific shares in Q1 2016, an estimated $9K.
Crosspoint Capital Strategies first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 9 quarters.
Crosspoint Capital Strategies's Thermo Fisher Scientific position peaked at $1.43M in Q4 2014.
1,024 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.